AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -29.2% | 36,533 | -14.2% | 0.00% | – |
| Q4 2021 | $24,000 | -41.5% | 42,565 | +70.5% | 0.00% | – |
| Q3 2021 | $41,000 | -50.0% | 24,967 | -49.4% | 0.00% | – |
| Q2 2021 | $82,000 | +1950.0% | 49,347 | +375.8% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 10,371 | -2.6% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 10,645 | +3.2% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 10,313 | -13.9% | 0.00% | – |
| Q3 2018 | $6,000 | -73.9% | 11,976 | +14.6% | 0.00% | – |
| Q2 2018 | $23,000 | -59.6% | 10,447 | -35.7% | 0.00% | -100.0% |
| Q3 2014 | $57,000 | -65.7% | 16,255 | -18.5% | 0.00% | -50.0% |
| Q2 2014 | $166,000 | -17.0% | 19,935 | -36.7% | 0.00% | -33.3% |
| Q1 2014 | $200,000 | +52.7% | 31,498 | +80.3% | 0.00% | 0.0% |
| Q3 2013 | $131,000 | +35.1% | 17,465 | +4.4% | 0.00% | +50.0% |
| Q2 2013 | $97,000 | – | 16,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |